Get started
Author

August R. Buchhalter

Observed names: A Buchhalter, A R Buchhalter, A. Buchhalter, A. R. Buchhalter, AR Buchhalter, August Buchhalter, August R Buchhalter, August R. Buchhalter, PhD
OpenAlex ID: A5113864665
Pharmacotherapy for Nicotine Dependence
2005 · J. E. Henningfield, R. V. Fant, et al. · CA A Cancer Journal for Clinicians · 232
PDF
Computerized behavior therapy for opioid-dependent outpatients: A randomized controlled trial.
2008 · Warren K. Bickel, Lisa A. Marsch, et al. · Experimental and Clinical Psychopharmacology · 222
Tobacco abstinence symptom suppression: the role played by the smoking‐related stimuli that are delivered by denicotinized cigarettes
2005 · August R. Buchhalter, Michelle C. Acosta, et al. · Addiction · 107
Evaluating acute effects of potential reduced-exposure products for smokers: Clinical laboratory methodology
2002 · Alison Breland, August Buchhalter, et al. · Nicotine & Tobacco Research · 73
Urine cotinine as an index of smoking status in smokers during 96-hr abstinence: Comparison between gas chromatography/mass spectrometry and immunoassay test strips
2004 · Michelle Acosta, August Buchhalter, et al. · Nicotine & Tobacco Research · 59
Novel Pharmacological Approaches for Treating Tobacco Dependence and Withdrawal
2008 · August R Buchhalter, Reginald V Fant, et al. · Drugs · 57
Nicotine delivery systems
2005 · Saul Shiffman, Reginald V Fant, et al. · Expert Opinion on Drug Delivery · 49
An Open-Label, Randomized, Controlled, Crossover Study to Assess Nicotine Pharmacokinetics and Subjective Effects of the JUUL System with Three Nicotine Concentrations Relative to Combustible Cigarettes in Adult Smokers
2021 · Nicholas I Goldenson, Ian M Fearon, et al. · Nicotine & Tobacco Research · 45
PDF
Abuse liability assessment of the JUUL system in four flavors relative to combustible cigarette, nicotine gum and a comparator electronic nicotine delivery system among adult smokers
2020 · Nicholas I. Goldenson, August R. Buchhalter, et al. · Drug and Alcohol Dependence · 42
Pharmacotherapy for Tobacco Dependence
2009 · Reginald V. Fant, August R. Buchhalter, et al. · Handbook of experimental pharmacology · 34
Rapid absorption of nicotine from new nicotine gum formulations
2008 · Saul Shiffman, Edward J. Cone, et al. · Pharmacology Biochemistry and Behavior · 33
Abuse liability assessment of the JUUL system in two nicotine concentrations compared to combustible cigarette, nicotine gum and comparator electronic nicotine delivery system
2020 · Nicholas I. Goldenson, August R. Buchhalter, et al. · Drug and Alcohol Dependence · 29
PDF
Human Abuse Potential of the New Opioid Analgesic Molecule NKTR-181 Compared with Oxycodone
2016 · Lynn Webster, Jack Henningfield, et al. · Pain Medicine · 29
PDF
The relationship between temporal discounting and the prisoner's dilemma game in intranasal abusers of prescription opioids
2006 · Richard Yi, August R. Buchhalter, et al. · Drug and Alcohol Dependence · 27
Buprenorphine medication versus voucher contingencies in promoting abstinence from opioids and cocaine.
2009 · Mohit P. Chopra, Reid D. Landes, et al. · Experimental and Clinical Psychopharmacology · 26
Acute effects of AdvanceTM: a potential reduced exposure product for smokers: Figure 1
2002 · A B Breland, S E Evans, et al. · Tobacco Control · 24
PDF
Relative Potency of levo-α-Acetylmethadol and Methadone in Humans under Acute Dosing Conditions
1999 · Thomas Eissenberg, Maxine L. Stitzer, et al. · Journal of Pharmacology and Experimental Therapeutics · 23
The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users
2023 · Megan J. Shram, Jack E. Henningfield, et al. · Translational Psychiatry · 22
PDF
Behavioral economic demand metrics for abuse deterrent and abuse potential quantification
2019 · Lindsay P. Schwartz, Peter G. Roma, et al. · Drug and Alcohol Dependence · 20
Barbiturate Detection in Oral Fluid, Plasma, and Urine
2010 · Dean Fritch, Kristen Blum, et al. · Therapeutic Drug Monitoring · 17
REL-1017 (esmethadone; d-methadone) does not cause reinforcing effect, physical dependence and withdrawal signs in Sprague Dawley rats
2022 · Jack Henningfield, David Gauvin, et al. · Scientific Reports · 15
PDF
Laboratory-based testing to evaluate abuse-deterrent formulations and satisfy the Food and Drug Administration's recommendation for Category 1 Testing
2017 · Christopher Altomare, BS, Eric R. Kinzler, PhD, et al. · Journal of Opioid Management · 9
The ALERRT® instrument: a quantitative measure of the effort required to compromise prescription opioid abuse-deterrent tablets
2017 · Edward J. Cone, August R. Buchhalter, et al. · The American Journal of Drug and Alcohol Abuse · 6
Evaluation of electronic nicotine delivery systems: Regulatory precedents from the FDA 2013 draft guidance for abuse-deterrent opioids
2015 · Jack Henningfield, Edward J. Cone, et al. · Drug and Alcohol Dependence · 6
Behavioral pharmacology contributions to regulation of drug and tobacco products by the Food and Drug Administration.
2016 · Jack E. Henningfield, August R. Buchhalter, et al. · Behavior Analysis Research and Practice · 4
Works count: 42
Citation count: 1,218
H-index: 19
I10-index: 21
Year
Topic
Type